Table 1 Demographics of seropositive and seronegative subjects collected in 2020 (study 1)
From: Proteome profiling of home-sampled dried blood spots reveals proteins of SARS-CoV-2 infections
Seropositive (IgM+IgG+) | Seronegative (IgM−IgG−) | P-value | |
|---|---|---|---|
Sample numbers | 44 | 37 | |
Sex | |||
Female | 25 (56.8%) | 20 (54.1%) | 0.826 |
Male | 19 (43.2%) | 17 (45.9%) | |
Age groups | |||
20–29 | 14 (31.8%) | 13 (35.1%) | 1 |
30–39 | 8 (18.2%) | 7 (18.9%) | |
40–49 | 8 (18.2%) | 6 (16.2%) | |
50–59 | 5 (11.4%) | 4 (10.8%) | |
60–69 | 8 (18.2%) | 6 (16.2%) | |
70–74 | 1 (2.3%) | 1 (2.7%) | |
Flu-like symptoms | |||
No | 4 (9.1%) | 2 (5.4%) | 0.417 |
Yes, fever | 19 (43.2%) | 19 (51.4%) | |
Yes, mild | 12 (27.3%) | 13 (35.1%) | |
Yes, severe | 3 (6.8%) | 0 (0%) | |
Missing | 6 (13.6%) | 3 (8.1%) | |
Respiratory symptoms | |||
No | 27 (61.4%) | 20 (54.1%) | 0.918 |
Yes | 4 (9.1%) | 5 (13.5%) | |
Coughing | 5 (11.4%) | 4 (10.8%) | |
Difficulty breathing | 5 (11.4%) | 4 (10.8%) | |
Both | 3 (6.8%) | 4 (10.8%) | |
Missing | 0 (%) | 0 (%) | |
